Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
about
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinomaThymic malignancies: from clinical management to targeted therapies.Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.
P2860
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Combined etoposide, ifosfamide ...... arcinoma. A French experience.
@en
Combined etoposide, ifosfamide ...... arcinoma. A French experience.
@nl
type
label
Combined etoposide, ifosfamide ...... arcinoma. A French experience.
@en
Combined etoposide, ifosfamide ...... arcinoma. A French experience.
@nl
prefLabel
Combined etoposide, ifosfamide ...... arcinoma. A French experience.
@en
Combined etoposide, ifosfamide ...... arcinoma. A French experience.
@nl
P2093
P1476
Combined etoposide, ifosfamide ...... carcinoma. A French experience
@en
P2093
Frédéric Grassin
Jacques Margery
Jean-Jacques Bretel
Michel André
Nicolas Paleiron
Philippe Terrier
Pierre Ruffié
Raffaele Caliandro
P304
P356
10.1097/JTO.0B013E3181DB3DEE
P577
2010-06-01T00:00:00Z